Company Name
Pmv Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US69353Y1038
CIK:
0001699382
CUSIP:
69353Y103
Currency:
USD
Full Time Employees:
54
Phone:
609 642 6670
Website:
https://www.pmvpharma.com
Fiscal Year End:
December
IPO Date:
Sep 25, 2020
Description:
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Address:
400 Alexander Park Drive, Princeton, NJ, United States, 08540